K-V Pharmaceutical (KV-A) Reports Q4 Loss of $0.54/Share
Tweet
Share
E-mailGet Alerts KV-A Hot Sheet
Price: $0.32 --0%
Financial Fact:
Net income (loss): -37.8M
Today's EPS Names:
SFST, VLTO, CLIR, More
Financial Fact:
Net income (loss): -37.8M
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
K-V Pharmaceutical (NYSE: KV-A) reported Q4 EPS of ($0.54), versus ($3.04) reported last year.
For earnings history and earnings-related data on K-V Pharmaceutical (KV-A) click here.
For earnings history and earnings-related data on K-V Pharmaceutical (KV-A) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- KKR Real Estate Finance Trust (KREF) Tops Q1 EPS by 4c
- Stride Inc. (LRN) Tops Q3 EPS by 17c, provides guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
